Bio-Techne (TECH) Dividends Paid - Common Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.12% |
| Dec 31, 2025 | 0.13% |
| Sep 30, 2025 | 0.17% |
| Jun 30, 2025 | 0.21% |
| Mar 31, 2025 | 0.49% |
| Dec 31, 2024 | 0.87% |
| Sep 30, 2024 | 0.84% |
| Jun 30, 2024 | 0.81% |
| Mar 31, 2024 | 0.80% |
| Dec 31, 2023 | 0.77% |
| Sep 30, 2023 | 0.96% |
| Jun 30, 2023 | 0.92% |
| Mar 31, 2023 | 0.96% |
| Dec 31, 2022 | 0.94% |
| Sep 30, 2022 | 0.96% |
| Jun 30, 2022 | 1.73% |
| Mar 31, 2022 | 1.04% |
| Dec 31, 2021 | 1.05% |
| Sep 30, 2021 | 0.92% |
| Jun 30, 2021 | 0.89% |
| Mar 31, 2021 | 0.90% |
| Dec 31, 2020 | 0.81% |
| Sep 30, 2020 | 0.73% |
| Jun 30, 2020 | 0.61% |
| Mar 31, 2020 | 0.66% |
| Dec 31, 2019 | 0.56% |
| Sep 30, 2019 | 1.19% |
| Jun 30, 2019 | 1.12% |
| Mar 31, 2019 | 1.10% |
| Dec 31, 2018 | 1.11% |
| Sep 30, 2018 | 1.77% |
| Jun 30, 2018 | 1.72% |
| Mar 31, 2018 | 1.65% |
| Dec 31, 2017 | 1.65% |
| Sep 30, 2017 | 3.01% |
| Jun 30, 2017 | 2.23% |
| Mar 31, 2017 | 2.96% |
| Dec 31, 2016 | 2.88% |
| Sep 30, 2016 | 3.54% |
| Jun 30, 2016 | 3.50% |
| Mar 31, 2016 | 3.50% |
| Dec 31, 2015 | 3.52% |
| Sep 30, 2015 | 4.32% |
| Jun 30, 2015 | 4.17% |
| Mar 31, 2015 | 4.15% |
| Dec 31, 2014 | 4.14% |
| Sep 30, 2014 | 4.26% |